Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Glucotrack, Inc.GCTK · Entity 8422 | Director | October 04, 2022 | March 29, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Glucotrack, Inc.
Report date October 04, 2022 · Filed March 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 1,922 |
Ending reported balance
After 2025-03-26 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-10-04 · Grant · Acquired 44 · Balance 195 Row 2 · 2024-04-08 · Grant · Acquired 229 · Balance 424 Row 3 · 2025-03-26 · Grant · Acquired 1,498 · Balance 1,922 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2025 Filed Mar 29, 2025 01:05 UTC | Glucotrack, Inc. GCTK · Entity 8422 | GrantCommon Stock, par value $0.001 per share | 1,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001474506-25-000068 · primary_doc.xml · nonDerivative · entry 3 Danzig Allen · CIK 0001905433 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,922 Read SEC document |
| April 08, 2024 Filed Mar 29, 2025 01:05 UTC | Glucotrack, Inc. GCTK · Entity 8422 | GrantCommon Stock, par value $0.001 per share | 229 | $0.00 | $0.00 |
DisclosureSEC source: 0001474506-25-000068 · primary_doc.xml · nonDerivative · entry 2 Danzig Allen · CIK 0001905433 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424 Read SEC document |
| October 04, 2022 Filed Mar 29, 2025 01:05 UTC | Glucotrack, Inc. GCTK · Entity 8422 | GrantCommon Stock, par value $0.001 per share | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001474506-25-000068 · primary_doc.xml · nonDerivative · entry 1 Danzig Allen · CIK 0001905433 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.